METROPOLITAN LIFE INSURANCE CO/NY - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 1 filers reported holding THERAVANCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$638,000
+46.7%
60,5760.0%0.01%
+66.7%
Q3 2015$435,000
-60.3%
60,5760.0%0.00%
-62.5%
Q2 2015$1,095,000
+9.8%
60,576
-4.5%
0.01%
+14.3%
Q1 2015$997,000
+11.0%
63,4400.0%0.01%
+16.7%
Q4 2014$898,000
-17.2%
63,4400.0%0.01%
-25.0%
Q3 2014$1,084,000
-42.6%
63,4400.0%0.01%
-38.5%
Q2 2014$1,889,000
+1024.4%
63,440
+1071.3%
0.01%
+1200.0%
Q1 2014$168,000
-13.0%
5,4160.0%0.00%0.0%
Q4 2013$193,000
-12.7%
5,4160.0%0.00%
-50.0%
Q3 2013$221,000
+12.8%
5,416
+6.4%
0.00%0.0%
Q2 2013$196,0005,0880.00%
Other shareholders
THERAVANCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders